Autism and Parkinson’s disease have long been treated as separate conditions, one rooted in early brain development and the other in aging and degeneration. New research is now pointing to a shared biological glitch deep in the brain that links them in unexpected ways. Scientists are tracing that connection to subtle defects in dopamine systems and overlapping genes, a shift that could reshape how both disorders are understood and eventually treated.
The emerging picture suggests that a hidden neural defect may increase the odds that some autistic people later develop Parkinson-like symptoms, even as most will never receive a Parkinson diagnosis. That possibility is prompting fresh debate about screening, long term care and how families should interpret this evolving science without panic.
From statistical clue to concrete risk
The first hints of a relationship came from population studies that noticed more Parkinson diagnoses among people with an autism history than would be expected by chance. A large Swedish analysis of health registers reported that individuals with an autism diagnosis were four times more likely to develop Parkinson’s disease or related movement disorders compared with people without autism, even after accounting for psychiatric medication and mental health factors. That work, described as a Link Found Between Onset Parkinson Risk, suggested that the association was strongest for early onset forms that appear before typical retirement age.
Another study that drew on national data sets came to a similar conclusion using a different method. Researchers reported that autistic people were three times more likely to develop Parkinson-like symptoms than non autistic peers, based on an analysis of 2.2 million individuals that identified 33 437 people with autism, 26 917 with Parkinson or related disability, and 13 302 with both conditions. That work, described as the Largest study of its kind, also found that relatives of autistic people had an elevated risk of Parkinson-like disorders, hinting at shared genetic or environmental factors within families rather than a coincidence of diagnosis.
A Swedish team quantifies the danger
Researchers at Karolinska Institutet in Stockholm have gone further by tying the autism Parkinson link to specific brain chemistry. Their work on national Swedish registers concluded that people with an autism diagnosis were four times more likely to develop Parkinson’s disease, and that Dopamine can be involved in this increased risk. The group described how the association held even when they adjusted for psychiatric medication use, which can itself cause tremors or stiffness, strengthening the case that a biological connection runs deeper than side effects. Their summary that Autism is linked to elevated risk of Parkinson’s disease has been shared through both Swedish language and English language channels, including Autism linked updates and mirrored material on Karolinska’s broader portal at ki.se.
The Swedish communication arm also highlighted the human face of the findings through an Image credited to Photo: Kong Kong, underscoring that the numbers represent real people navigating both Autism and Parkinson in the same lifetime. Parallel coverage in Swedish at nyheter.ki.se described how People with an autism diagnosis are at a higher risk of developing Parkinson’s disease and related disorders, and placed the work within Karolinska’s broader research and education ecosystem that spans nyheter.ki.se and education.ki.se. Together, these efforts frame the risk as real but still affecting a minority of autistic individuals, with researchers stressing that the goal is better monitoring and care rather than alarm.
The hidden neural defect in dopamine transport
While register studies map risk at the population level, a different line of work is pointing to a specific neural defect that might sit at the core of the link. Scientists at the University of Missouri used brain imaging to examine dopamine transporters in autistic adults and found abnormalities usually seen in Parkinson’s disease. These Surprising Biomarkers involved Abnormalities in how dopamine is moved and recycled in key motor circuits, a pattern that had not been widely documented in autism before. Their findings, described in detail in a report on how Autism and Parkinson Share a Hidden Neural Defect, suggest that some autistic brains carry a silent vulnerability in the same dopamine pathways that later degenerate in Parkinson’s disease.
The Missouri team also shared the work in more public facing formats, including a social media explainer that asked Mar Why are people with autism 6x more likely to develop Parkinson’s, and credited Researchers at Mizzou with tracing the answer to the brain’s dopamine transporters. That clip, posted on Researchers at Mizzou, framed the discovery as a potential biomarker that might flag which autistic individuals have the highest risk of Parkinson-like symptoms long before tremors appear. A companion analysis on Autism and Parkinson highlighted that these defects in dopamine transporters could help explain why some autistic people respond differently to medications that target dopamine and why movement difficulties sometimes emerge earlier than expected.
Shared genes blur the line between Neurodevelopmental and Neurodegenerative Disorders
Genetics has been another key bridge between autism and Parkinson’s disease. More than a decade ago, researchers studying Two children with Asperger syndrome discovered disruptions in the PARK2 gene, which had already been implicated in early onset Parkinson’s disease. Their findings, published in the American Journal of Medical Genetics, suggested that mutations in PARK2 might contribute to both conditions in at least some families. A detailed summary of that work appears in a report on Genetics of Parkinson that linked PARK2 to autism, and is supported by primary data in Discovered material and gene level curation for PARK2 on PARK2 at the Simons Foundation Autism Research Initiative.
Other genes have since joined this overlapping list. Reviews of shared susceptibility genes have pointed to UBE3A, a gene best known for its role in Angelman syndrome and autism, as another player that may influence dopaminergic neurons and Parkinson risk. A detailed discussion of UBE3A, captured in an analysis titled Discovered, describes how disruptions in protein tagging and degradation can affect brain circuits involved in both movement and social behavior. Broader summaries of shared pathways between autism and Parkinson, such as a feature on Unveiling Common Ground in Neurodevelopmental and Neurodegenerative Disorders, describe how converging evidence from PARK2, UBE3A and other genes points to common stress on mitochondria, protein recycling and dopamine producing neurons.
What higher risk means for autistic people and families
The emerging science raises practical questions for autistic adults, their relatives and clinicians. One concern is how to monitor for early Parkinson-like symptoms without pathologizing every movement quirk that can accompany autism. Clinical commentaries, such as an explainer on Despite the potential link, stress that autism and Parkinson’s disease remain two distinct disorders with different diagnostic criteria and treatment paths. They argue that even if risk is higher on a relative scale, the absolute chance that any given autistic person will develop Parkinson’s disease is still modest, and that families should focus on known health priorities such as mental health support, sleep, and cardiovascular care.
At the same time, clinicians are beginning to ask whether certain subgroups of autistic people might benefit from more targeted screening. The Swedish register work suggests that early onset Parkinson risk is particularly elevated in those with co occurring intellectual disability or severe motor challenges, and that Dopamine can be involved in both the autism profile and later movement symptoms. A feature on exploring people with autism and Parkinson disease describes how neurologists are adapting assessment tools so that communication differences do not mask early signs of rigidity or tremor. Parallel coverage on Dopamine and Parkinson risk emphasizes that more research is needed to determine whether medications that protect dopamine neurons in high risk Parkinson families might someday be relevant for a subset of autistic adults.
